Diagnostic and Treatment Considerations in Restless Legs Syndrome Complicated by Diabetic Neuropathy

• Published in: Current diabetes reports Vol. 21; no. 12; p. 66
• Main Authors: Garg, Anisha, Chilakamarri, Priyanka, Koo, Brian B.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.12.2021; Springer Nature B.V
• Subjects: Comorbidity; Diabetes; Diabetes Mellitus, Type 2; Diabetic Neuropathies - complications; Diabetic Neuropathies - diagnosis; Diabetic Neuropathies - drug therapy; Diabetic neuropathy; Humans; Medical diagnosis; Medicine; Medicine & Public Health; Other Forms of Diabetes and Its Complications (JJ Nolan and H Thabit; Peripheral neuropathy; Prevalence; Restless legs syndrome; Restless Legs Syndrome - complications; Restless Legs Syndrome - diagnosis; Restless Legs Syndrome - drug therapy; Section Editors; Topical Collection on Other Forms of Diabetes and Its Complications; Diabetic neuropathy; RLS mimics; Peripheral neuropathy; Restless leg syndrome
• ISSN: 1534-4827; 1539-0829; 1539-0829
• DOI: 10.1007/s11892-021-01431-2

Purpose of Review Diabetic neuropathy from type I diabetes (DMI), type II diabetes (DMII), or gestational diabetes commonly occurs concurrently with restless legs syndrome (RLS) with an estimated prevalence in DMII specifically of 17.7 to 45%. The diagnosis of RLS can be obscured by symptoms of peripheral neuropathy, which may be similar to those of RLS, but also by other RLS mimics, including nocturnal leg cramps or akathisia. The purpose of this review is to outline a framework for considering comorbid diabetic neuropathy and RLS by discussing RLS and its association with peripheral nerve disease, diabetes, and sleep disruption. Treatment for patients with both diabetic neuropathy and RLS may differ from treatment of persons with solely RLS or diabetic neuropathy; key points in this difference are discussed. Finally, a treatment algorithm is provided to guide the approach to treating patients with comorbid RLS and diabetic neuropathy. Recent Findings There have been several revisions of the RLS diagnostic criteria which in addition to the main four essential criteria of having (1) an urge to move the legs which is (2) exacerbated by rest, (3) relieved temporarily by movement, and (4) occurs in the evening or night time, now includes a consideration for RLS mimics, requiring that (5) symptoms not be explained by any other symptoms. Additionally, the treatment of both diabetic neuropathy and RLS has evolved to focus first on controlling the blood glucose, avoiding exacerbating medications, supplementing with iron if serum ferritin is low, and starting pharmacotherapy with alpha-2-delta ligands such as gabapentin or pregabalin. Summary Knowledge of the prevalence of peripheral neuropathy with RLS, revised RLS diagnostic criteria, and a general treatment algorithm for the combination of peripheral neuropathy and RLS is critical to providing appropriate care to patients suffering from these two diseases.